Furthermore, Tet2 ablation-mediated accumulation MaSCs and bi-lineage progenitor cells are associated with poor differentiation tumor phenotype and endocrine resistance19,20 (Fig. 4 and Supplementary Fig. 3e, f), which potentially underlies the development of intrinsic resistance to anti-estrogen treatments in aggressive breast cancer. This evidence concerns the gene TET2 and breast cancer.